{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:15:45Z","timestamp":1776867345484,"version":"3.51.2"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leo Pharma AS"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160096","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T18:55:46Z","timestamp":1473447346000},"page":"e0160096","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate"],"prefix":"10.1371","volume":"11","author":[{"given":"Steffen","family":"Emmert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger A.","family":"Haenssle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Zibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria H.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Litman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"ref1","first-page":"551","article-title":"Actinic keratoses","volume":"54","author":"P Babilas","year":"2003","journal-title":"Hautarzt"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study","volume":"133","author":"SC Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","article-title":"Prevalence of solar damage and actinic keratosis in a Merseyside population","volume":"142","author":"AA Memon","year":"2000","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"ref4","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1016\/j.jaad.2012.09.052","article-title":"Prevalence and awareness of actinic keratosis: barriers and opportunities","volume":"68","author":"T Rosen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1040-8428(01)00185-8","article-title":"Chemoprevention of human skin cancer","volume":"41","author":"JG Einspahr","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"V Ratushny","year":"2012","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1056\/NEJMicm071130","article-title":"Images in clinical medicine. Fluorescence diagnosis of subclinical actinic keratoses","volume":"358","author":"O Sanmartin","year":"2008","journal-title":"N Engl J Med"},{"key":"ref8","first-page":"39","article-title":"Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer","volume":"3","author":"JL Cohen","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.139.1.66","article-title":"The actinic (solar) keratosis: a 21st-century perspective","volume":"139","author":"W Fu","year":"2003","journal-title":"Arch Dermatol"},{"issue":"Suppl. 61","key":"ref10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.146.s61.6.x","article-title":"From actinic keratosis to squamous cell carcinoma","volume":"146","author":"JP Ortonne","year":"2002","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archdermatol.2009.378","article-title":"Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression","volume":"146","author":"RS Padilla","year":"2010","journal-title":"Arch Dermatol"},{"issue":"Suppl. 2","key":"ref12","doi-asserted-by":"crossref","first-page":"s18","DOI":"10.1111\/j.1365-2133.2007.08267.x","article-title":"Pathology and pathobiology of actinic (solar) keratosis\u2014an update","volume":"157","author":"J Roewert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1524-4725.1995.tb00141.x","article-title":"Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant?","volume":"21","author":"RM Hurwitz","year":"1995","journal-title":"Dermatol Surg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","article-title":"Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma","volume":"37","author":"MA Mittelbronn","year":"1998","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10227-001-0041-x","article-title":"The majority of cutaneous squamous cell carcinomas arise in actinic keratoses","volume":"6","author":"DJ Czarnecki","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"VD Criscione","year":"2009","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1241606","article-title":"14-step synthesis of (+)-ingenol from (+)-3-carene","volume":"341","author":"L J\u00f8rgensen","year":"2013","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaad.2009.01.008","article-title":"Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis","volume":"60","author":"L Anderson","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref19","first-page":"633","article-title":"The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers","volume":"164","author":"JR Ramsay","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-0960.2008.00497.x","article-title":"PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study","volume":"50","author":"G Siller","year":"2009","journal-title":"Australas J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"M Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CCID.S28905","article-title":"New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel","volume":"5","author":"B Berman","year":"2012","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"RH Rosen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1535-7163.1651.3.12","article-title":"Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells","volume":"3","author":"SK Gillespie","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"SM Ogbourne","year":"2004","journal-title":"Cancer Res"},{"key":"ref26","first-page":"1181","article-title":"Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells","volume":"11","author":"M Stahlhut","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2004-10-4117","article-title":"PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC","volume":"106","author":"P Hampson","year":"2005","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"N Kedei","year":"2004","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","article-title":"Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate","volume":"177","author":"JM Challacombe","year":"2006","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00262-008-0458-9","article-title":"The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner","volume":"57","author":"P Hampson","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/jid.2011.418","article-title":"Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches","volume":"132","author":"SJ Cozzi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","article-title":"The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature","volume":"70","author":"L Li","year":"2010","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjd.12036","article-title":"Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire","volume":"168","author":"S Esmann","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"M Sch\u00f6n","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"29899","DOI":"10.1074\/jbc.M112.391243","article-title":"MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion","volume":"287","author":"N Xu","year":"2012","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2009.03.025","article-title":"Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies","volume":"27","author":"TT Le","year":"2009","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bse0380009","article-title":"Caspases and apoptosis","volume":"39","author":"HG Salvesen","year":"2002","journal-title":"Essays Biochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.2009.07691.x","article-title":"The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells","volume":"145","author":"AM Olsnes","year":"2009","journal-title":"Br J Haematol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","article-title":"Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin","volume":"29","author":"MT Fern\u00e1ndez-Figueras","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref40","first-page":"741","article-title":"Efficacy and Safety of Ingenol Mebutate 0.015% Gel After Cryosurgery of Actinic Keratosis: 12-Month Results","volume":"13","author":"B Berman","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Ingenol Mebutate Signals via PKC\/MEK\/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2","volume":"14","author":"SN Freiberger","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","article-title":"MicroRNAs and potential target interactions in psoriasis","volume":"58","author":"JR Zibert","year":"2010","journal-title":"J Dermatol Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.1002218","article-title":"Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu","volume":"186","author":"AA Divekar","year":"2011","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e1003451","DOI":"10.1371\/journal.ppat.1003451","article-title":"miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation","volume":"9","author":"S Kelada","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2230.2011.04158.x","article-title":"Circulating miR-142-3p levels in patients with systemic sclerosis","volume":"37","author":"K Makino","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1155\/2011\/247654","article-title":"MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction","volume":"31","author":"N Zidar","year":"2011","journal-title":"Dis Markers"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ydbio.2011.06.004","article-title":"miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification","volume":"256","author":"X Nissan","year":"2011","journal-title":"Dev Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2013.05.032","article-title":"miR-211 promotes the progression of head and neck carcinomas by targeting TGF\u03b2RII","volume":"337","author":"TH Chu","year":"2013","journal-title":"Cancer Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature06642","article-title":"A skin microRNA promotes differentiation by repressing 'stemness'","volume":"452","author":"R Yi","year":"2008","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cfg.239","article-title":"Early gene expression in wounded human keratinocytes revealed by DNA microarray analysis","volume":"4","author":"MA Dayem","year":"2003","journal-title":"Comp Funct Genomics"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.burns.2011.10.014","article-title":"MicroRNA profiling in denatured dermis of deep burn patients","volume":"38","author":"P Liang","year":"2012","journal-title":"Burns"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1947601911408888","article-title":"Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression","volume":"2","author":"H Noh","year":"2011","journal-title":"Genes Cancer"},{"issue":"Part 2","key":"ref53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis")","volume":"42","author":"CJ Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T01:48:34Z","timestamp":1657244914000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160096"}},"subtitle":[],"editor":[{"given":"Naoki","family":"Oiso","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160096","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}